138 related articles for article (PubMed ID: 25502788)
1. The Role of HLA in MS Susceptibility and Phenotype.
Greer JM
Curr Top Behav Neurosci; 2015; 26():1-27. PubMed ID: 25502788
[TBL] [Abstract][Full Text] [Related]
2. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
Liguori M; Healy BC; Glanz BI; Khoury SJ; Moscufo N; Weiner HL; De Jager PL; Guttmann CR
Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117
[TBL] [Abstract][Full Text] [Related]
3. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.
Salier JP; Sesboüé R; Martin-Mondière C; Daveau M; Cesaro P; Cavelier B; Coquerel A; Legrand L; Goust JM; Degos JD
J Clin Invest; 1986 Aug; 78(2):533-8. PubMed ID: 3461005
[TBL] [Abstract][Full Text] [Related]
4. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
[TBL] [Abstract][Full Text] [Related]
5. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
[TBL] [Abstract][Full Text] [Related]
6. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
[TBL] [Abstract][Full Text] [Related]
7. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
Fernandez-Morera JL; Rodriguez-Rodero S; Tunon A; Martinez-Borra J; Vidal-Castineira JR; Lopez-Vazquez A; Rodrigo L; Rodrigo P; González S; Lahoz CH; Lopez-Larrea C
Tissue Antigens; 2008 Jul; 72(1):54-9. PubMed ID: 18588574
[TBL] [Abstract][Full Text] [Related]
8. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.
Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M
Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771
[TBL] [Abstract][Full Text] [Related]
9. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.
Burfoot RK; Jensen CJ; Field J; Stankovich J; Varney MD; Johnson LJ; Butzkueven H; Booth D; Bahlo M; Tait BD; Taylor BV; Speed TP; Heard R; Stewart GJ; Foote SJ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2008 Jan; 71(1):42-50. PubMed ID: 17971048
[TBL] [Abstract][Full Text] [Related]
10. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
11. The relationship between HLA-DRB1 alleles and optic neuritis in Irish patients and the risk of developing multiple sclerosis.
Tuwir I; Dunne C; Crowley J; Saddik T; Murphy R; Cassidy L
Br J Ophthalmol; 2007 Oct; 91(10):1288-92. PubMed ID: 17895416
[TBL] [Abstract][Full Text] [Related]
12. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
[TBL] [Abstract][Full Text] [Related]
13. Genetic predisposition to multiple sclerosis as revealed by immunoprinting.
Epplen C; Jäckel S; Santos EJ; D'Souza M; Poehlau D; Dotzauer B; Sindern E; Haupts M; Rüde KP; Weber F; Stöver J; Poser S; Gehler W; Malin JP; Przuntek H; Epplen JT
Ann Neurol; 1997 Mar; 41(3):341-52. PubMed ID: 9066355
[TBL] [Abstract][Full Text] [Related]
14. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases.
Lobnig BM; Chantelau E; Vidgrén G; Van Landeghem AA; Kinnunen L; Tuomilehto-Wolf E
Diabetes Metab; 2002 Jun; 28(3):217-21. PubMed ID: 12149602
[TBL] [Abstract][Full Text] [Related]
15. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
[TBL] [Abstract][Full Text] [Related]
16. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B
Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867
[TBL] [Abstract][Full Text] [Related]
17. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic studies of multiple sclerosis in the portuguese population.
Bettencourt A; Martins da Silva A; Pinho E Costa P; Martins Silva B
Acta Med Port; 2012; 25(4):224-30. PubMed ID: 23079250
[TBL] [Abstract][Full Text] [Related]
19. [11th International Histocompatibility Workshop 1991: Personal data for the Multiple Sclerosis Study].
Wegener S; Falk U; Lakner K; Meyer-Riennecker HJ; Hauptmann G; Uring-Lambert B
Beitr Infusionsther; 1992; 30():324-31. PubMed ID: 1284726
[TBL] [Abstract][Full Text] [Related]
20. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
